NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

NeuroSense Therapeutics (NRSN) announced the issuance of a patent by the USPTO, entitled 'Compositions comprising Ciprofloxacin and ...

The interaction of celecoxib and rofecoxib with warfarin was studied. Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional ...

NeuroSense Therapeutics has been granted a key patent for the formulation of its treatment for amyotrophic lateral sclerosis, or ALS.

All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for ...

We evaluated opioid-sparing effects and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty. Methods: This was a prospective, randomized, observer-blind ...

A meta-analysis reveals triptans as the most effective acute migraine treatments, highlighting the need for their inclusion ...

It was three years before it subsided. I still have tinnitus, but it’s livable now. A. When most health care professionals ...

All active interventions showed superior efficacy compared with placebo for pain freedom at two hours (odds ratios from 1.73 ...

The newly granted patent, entitled "Compositions comprising Ciprofloxacin and Celecoxib" (US Patent No. US 12,097,185), relates to the novel formulation of PrimeC, NeuroSense's leading drug candidate ...

It may be directly related to your calf muscles—including the inner gastrocnemius and outer soleus muscles—or the tendons, ...

After hours: September 20 at 5:10 PM EDT Loading Chart for NRSN ...